FDA
-
-
-
-
-
-
-
Flex Pharma (FLKS) Reports Merger Agreement with Salarius Pharmaceuticals to Accelerate Clinical Development of Novel Epigenetic Therapy for Cancer
-
-
-
-
-
-
-
Flex Pharma Reports Year End 2017 Financial Results
-
-
-
-
-
-
-
Flex Pharma to Report Third Quarter 2017 Results on November 6, 2017
-
-
-
-
-
-
-
Flex Pharma (FLKS) Names William McVicar President and cEO
-
-
-
-
-
-
-
Flex Pharma (FLKS) Announces FDA Clearance for FLX-787 Phase 2 Trial in ALS Under IND
-
-
322,979 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

